Reversal of Experimental Posthepatectomy Liver Failure in Pigs: A New Application of Hepatocyte Bioreactors

Artificial Organs

Volumn 35, Issue 1, 2011, Pages 29-36

  Arkadopoulos, Nikolaos ^a   Kostopanagiotou, Georgia ^b   Nastos, Constantinos ^a   Papalois, Apostolos ^c   Papoutsidakis, Nikolaos ^a   Kalimeris, Konstantinos ^b   Defterevos, George ^a   Kanna, Themis ^a   Polyzois, Konstantinos ^a   Kampouroglou, George ^a   Kypriotis, Dimosthenis ^a   Costopanagiotou, Constantinos ^a   Pafiti, Agathi ^d   Tzanatos, Helen ^a   Smyrniotis, Vassilios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Experimental Research Department of ELPEN Pharma   (Greece)

^d Department of Pathology ^*  (Greece)

Author keywords

Acute liver failure; Bioartificial liver; Intracranial pressure; Major hepatectomy; Portacaval shunt

Indexed keywords

BIOCONVERSION; BIOREACTORS; MAMMALS; VENTILATION;

ACUTE LIVER FAILURE; BIOARTIFICIAL LIVER; EXPERIMENTAL MODELLING; HEPATOCYTES; INTRACRANIAL PRESSURE; LIVER FAILURE; MAJOR HEPATECTOMY; NEW APPLICATIONS; PORTACAVAL SHUNT; POSTOPERATIVE LIVER;

ARTIFICIAL ORGANS;

GLUCOSE; INFUSION FLUID;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BIOREACTOR; BRAIN EDEMA; EXTRACORPOREAL CIRCULATION; HEMODYNAMIC PARAMETERS; INTRACRANIAL PRESSURE; LIVER BIOPSY; LIVER CELL; LIVER FAILURE; LIVER NECROSIS; LIVER REGENERATION; LIVER RESECTION; NONHUMAN; OXYGENATOR; PORTOCAVAL SHUNT; PRIORITY JOURNAL; SWINE;

ANIMALIA; SUIDAE;

EID: 78651458351     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01016.x     Document Type: Article

References (24)

1. Mullin E, Metcalfe M, Maddern G. How much liver resection is too much? Am J Surg 2005;190:87-97.
2. Schindl M, Redhead D, Fearon K, Garden O, Wigmore S. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005;54:289-96.
3. Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio >or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 2007;204:22-33.
4. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1, 059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007;204:854-62. Discussion 862-854.
5. O'Grady J. Modern management of acute liver failure. Clin Liver Dis 2007;11:291-303.
6. Barshes NR, Gay AN, Williams B, Patel AJ, Awad SS. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies. J Am Coll Surg 2005;201:458-76.
7. Inderbitzin D, Muggli B, Ringger A, et al. Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients. J Gastrointest Surg 2005;9:1155-61. Discussion 1161-1152.
8. Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-7. Discussion 667-670.
9. Kamohara Y, Fujioka H, Eguchi S, Kawashita Y, Furui J, Kanematsu T. Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure. Artif Organs 2000;24:265-70.
10. Park JK, Lee DH. Bioartificial liver systems: current status and future perspective. J Biosci Bioeng 2005;99:311-9.
11. Ingram D, Legge K. Variations in deep body temperature in the young unrestrained pig over the 24 hour period. The J Physiology 1970;210:989.
12. Jalan R, SW OD, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999;354:1164-8.
13. Rozga J, Holzman MD, Ro MS, et al. Development of a hybrid bioartificial liver. Ann Surg 1993;217:502-9. Discussion 509-511.
14. Khalili TM, Navarro A, Ting P, et al. Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure. Artif Organs 2001;25:566-70.
15. Samuel D, Ichai P, Feray C, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation 2002;73:257-64.
16. Patzer JF 2nd, Lopez RC, Aggarwal S. Intracranial pressure observations in a canine model of acute liver failure supported by a bioartificial liver support system. Artif Organs 2007;31:834-9.
17. Kellersmann R, Gassel HJ, Buhler C, Thiede A, Timmermann W. Application of molecular adsorbent recirculating system in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver 2002;22(Suppl 2):56-8.
18. Rittler P, Ketscher C, Inthorn D, Jauch K, Hartl W. Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction-preliminary results. Liver Int 2004;24:136-41.
19. Fruhauf NR, Oldhafer KJ, Holtje M, et al. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surg 2004;136:47-56.
20. Sosef MN, Abrahamse LS, van de Kerkhove MP, Hartman R, Chamuleau RA, van Gulik TM. Assessment of the AMC-bioartificial liver in the anhepatic pig. Transplantation 2002;73:204-9.
21. Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-8. Discussion 828-829.
22. Ladurner R, Hochleitner B, Schneeberger S, et al. Extended liver resection and hepatic ischemia in pigs: a new, potentially reversible model to induce acute liver failure and study artificial liver support systems. Eur Surg Res 2005;37:365-9.
23. Suh KS, Lilja H, Kamohara Y, et al. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res 1999;85:243-50.
24. Singhal A, Neuberger J. Acute liver failure: bridging to transplant or recovery-are we there yet? J Hepatol 2007;46:557-64.